PC
AGN

Paulson & Co’s Allergan plc AGN Stock Holding History

Paulson & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-214,700
Closed -$45.1M – 118
2016
Q4 		$45.1M Hold
214,700
– – 0.57% 33
2016
Q3 		$49.4M Hold
214,700
– – 0.54% 31
2016
Q2 		$49.6M Hold
214,700
– – 0.5% 31
2016
Q1 		$57.5M Buy
+214,700
New +$61.5M 0.43% 34

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Paulson & Co's AGN Position: Q2 2020 in Review

Paulson & Co sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 602,130 shares — an estimated $107M sold.

Paulson & Co first reported a position in AGN in Q1 2014 and held it in 25 quarters. The position peaked at $2.18B in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Paulson & Co reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Paulson & Co sold 602,130 Allergan plc shares in Q2 2020, an estimated $107M.
  • Paulson & Co first reported a position in Allergan plc in Q1 2014 and held it in 25 quarters.
  • Paulson & Co's Allergan plc position peaked at $2.18B in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Paulson & Co's 13F filing for Q2 2020, filed 14 Aug 2020.